Today: 10 février 2026
Subscribe
Search result

Phantom 4 RTK/feed/category/dji-mavic-3e-pl- Page 54

Woodside Energy Group Ltd Stock (ASX:WDS, NYSE:WDS) Drops as CEO Meg O’Neill Exits for BP: Latest News, Analyst Forecasts, and What to Watch Next

Woodside Energy Group Ltd Stock (ASX:WDS, NYSE:WDS) Drops as CEO Meg O’Neill Exits for BP: Latest News, Analyst Forecasts, and What to Watch Next

Woodside Energy shares fell 2.6% to A$22.80 on December 18 after CEO Meg O’Neill resigned to become BP’s chief executive. Liz Westcott was named Acting CEO, effective immediately. Woodside said a permanent CEO will be appointed in the first quarter of 2026. O’Neill remains on gardening leave until March but forfeits her 2025 incentive and unvested shares.
18 décembre 2025
···
Bosch Limited Stock (BOSCHLTD) on Dec. 19, 2025: Share Price Slips, EV Push Builds, and Analysts Debate Valuation

Bosch Limited Stock (BOSCHLTD) on Dec. 19, 2025: Share Price Slips, EV Push Builds, and Analysts Debate Valuation

Bosch Limited shares traded at ₹35,649 around midday Friday, down 0.75% and marking a fifth consecutive session of declines. The company has scheduled a board meeting for February 6, 2026, to review quarterly results and announced its trading window will close from January 1 to February 8. Broader auto sector sentiment remained mixed.
19 décembre 2025
···
Robinhood Stock News Today (Dec. 19, 2025): HOOD Rises as Analysts Tout a Prediction-Markets “Supercycle” and WonderFi Deal Timeline Extends

Robinhood Stock News Today (Dec. 19, 2025): HOOD Rises as Analysts Tout a Prediction-Markets “Supercycle” and WonderFi Deal Timeline Extends

Robinhood shares rose 3.41% to $121.16 as of 15:14 UTC Friday after news that its proposed WonderFi acquisition deadline was extended to June 1, 2026. Trading volume reached 6 million shares, with market cap at $127.2 billion. The extension aims to allow more time for integration and regulatory approval in Canada. Wall Street analysts highlighted Robinhood’s prediction markets as a key growth driver.
19 décembre 2025
···
Nike Stock (NKE) Slides After Fiscal Q2 2026 Earnings: Tariffs, China Weakness, and Updated Wall Street Forecasts (Dec. 19, 2025)

Nike Stock (NKE) Slides After Fiscal Q2 2026 Earnings: Tariffs, China Weakness, and Updated Wall Street Forecasts (Dec. 19, 2025)

Nike shares fell about 8% Friday after reporting fiscal Q2 results that beat revenue and earnings forecasts but showed gross margin dropping 300 basis points to 40.6% and a 32% plunge in net income to $0.8 billion. Greater China sales fell 17% to $1.42 billion. Management warned margin pressure will persist next quarter.
19 décembre 2025
···
Imperial Brands PLC Stock (LSE: IMB) News and Forecast (Dec. 20, 2025): Fitch BBB Call, Buyback Momentum, and 2026 Catalysts

Imperial Brands PLC Stock (LSE: IMB) News and Forecast (Dec. 20, 2025): Fitch BBB Call, Buyback Momentum, and 2026 Catalysts

Fitch reaffirmed Imperial Brands’ ‘BBB’ rating with a Stable outlook, citing strong cash flow from tobacco and disciplined capital allocation. The company continued its £1.45 billion share buyback, purchasing over 388,000 shares on Dec. 18–19 at around 3,182p each. Fitch expects cigarettes to remain over 90% of revenue by 2028, with NGP at 4.4% in FY25. A $400 million litigation payment is projected for 2026.
20 décembre 2025
·
Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab Stock (RKLB) Hits Record High After $816M U.S. Space Force Satellite Win: News, Forecasts, and What’s Next

Rocket Lab shares jumped 17.69% to close at $70.52 on December 19 after winning an $816 million U.S. Space Development Agency contract to build 18 missile-defense satellites. The award, part of a $3.5 billion program, marks Rocket Lab’s largest deal and positions it as a prime contractor alongside Lockheed Martin, Northrop Grumman, and L3Harris.
20 décembre 2025
·
Robinhood (HOOD) Stock News, Forecasts and Analysis as of Dec. 20, 2025: Prediction Markets, AI “Cortex,” and Global Expansion Take Center Stage

Robinhood (HOOD) Stock News, Forecasts and Analysis as of Dec. 20, 2025: Prediction Markets, AI “Cortex,” and Global Expansion Take Center Stage

Robinhood shares closed at $121.35, valuing the company near $127 billion, after a year-to-date gain of almost 268%. The company is expanding into sports-focused prediction markets and pushing into Asia with an Indonesia entry plan. State regulators are reviewing whether Robinhood’s event contracts resemble unlicensed gambling. November data showed rising event contract volumes even as some traditional trading slowed.
20 décembre 2025
·
Uber (UBER) Stock Week Ahead: FTC Uber One Lawsuit Overhang Meets Robotaxi Momentum and Diverging Analyst Targets

Uber (UBER) Stock Week Ahead: FTC Uber One Lawsuit Overhang Meets Robotaxi Momentum and Diverging Analyst Targets

Uber shares closed the last full session at $79.31, down from above $90 earlier in December. The stock faces heightened volatility ahead of Christmas, with U.S. markets closing early Dec. 24 and shut Dec. 25. An expanded FTC lawsuit, joined by 21 states and D.C., alleges deceptive practices in Uber One subscriptions. Uber denies the charges.
21 décembre 2025
··
Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen shares closed at $174.80 on Dec. 19, up 2.88% with trading volume spiking to 15 million shares, well above the 50-day average. The stock remains about 5% below its 52-week high of $185.17. Recent filings show new institutional positions from Wedge Capital Management and Fluent Financial. Leqembi was added to China’s Commercial Insurance Innovative Drug List, effective Jan. 1, 2026.
21 décembre 2025
··
Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals joins the Nasdaq-100 before the U.S. market opens Dec. 22, prompting index-tracking funds to adjust positions. Shares last closed at $400.23. The company’s drug Amvuttra recently secured routine NHS use in England and Health Canada approval for ATTR cardiomyopathy. Alnylam also announced a $250 million manufacturing expansion and new FDA recognition for its technology platform.
22 décembre 2025
···
Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks shares rose 1.5% to $189.65 on Dec. 22 after news of an expanded Google Cloud partnership, reportedly worth nearly $10 billion over several years. The deal includes integrating Palo Alto’s AI security tools with Google Cloud services and expanding firewall and SASE deployments. Analysts highlighted the partnership’s potential to drive recurring revenue but noted execution risks remain.
22 décembre 2025
····
Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors Stock (ASO) Drops on Dec. 22, 2025: Nike Shockwaves, Q3 Results, Updated Guidance, Analyst Price Targets, and 2026 Forecasts

Academy Sports and Outdoors shares fell 4.64% to $51.21 on December 22, 2025, after Nike’s weak earnings and margin warnings hit the retail sector. The drop came despite Academy’s Q3 results showing profit growth, higher margins, and narrowed full-year guidance. Market cap stood near $3.45 billion.
22 décembre 2025
···
Philip Morris International (PM) Stock After Hours Today (Dec. 22, 2025): Closing Price, After-Hours Move, Analyst Forecasts, and What to Watch Before the Market Opens Dec. 23

Philip Morris International (PM) Stock After Hours Today (Dec. 22, 2025): Closing Price, After-Hours Move, Analyst Forecasts, and What to Watch Before the Market Opens Dec. 23

Philip Morris International closed up 1.82% at $159.70 on Monday, outperforming tobacco peers and snapping a two-day slide. After-hours trading saw the stock nearly unchanged at $159.65 as of 5:51 p.m. ET, with volume at 1.22 million shares. Regular session volume was about 6.9 million shares, trading between $157.12 and $161.18. The next ex-dividend date is December 26.
23 décembre 2025
·
Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

A Baltimore jury ordered Johnson & Johnson and spinoff Kenvue to pay over $1.5 billion in a talc cancer case, with J&J saying it will appeal. Kenvue shares traded at $16.98, about $1.15 below the implied $18.12 merger value based on Kimberly-Clark’s price, reflecting deal risk. The acquisition is expected to close in the second half of 2026. J&J has said it will cover Kenvue’s talc liabilities.
23 décembre 2025
···
Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next

Structure Therapeutics shares traded near $67.50 on Dec. 23, 2025, following strong Phase 2 data for its oral obesity drug aleniglipron, which showed up to 15.3% placebo-adjusted weight loss at 36 weeks. The company also closed a $747.5 million public offering after the trial results.
23 décembre 2025
····
Bristol-Myers Squibb (BMY) Stock News Today: Supreme Court Bid, Drug-Pricing Deals, Dividend Boost, and 2026 Forecasts (Dec. 23, 2025)

Bristol-Myers Squibb (BMY) Stock News Today: Supreme Court Bid, Drug-Pricing Deals, Dividend Boost, and 2026 Forecasts (Dec. 23, 2025)

Bristol-Myers Squibb shares traded near $54 midday Tuesday, down about 1%, after the company and Johnson & Johnson asked the U.S. Supreme Court to review challenges to Medicare drug price negotiations. Eliquis, a key Bristol Myers drug, is set for negotiated Medicare pricing starting January 1, 2026. Guggenheim reiterated a Buy rating on BMY despite new competition for its Camzyos therapy.
23 décembre 2025
··
Philip Morris International Stock (NYSE: PM) Today: News, Analyst Forecasts, Dividend Outlook, and What’s Driving Shares on Dec. 23, 2025

Philip Morris International Stock (NYSE: PM) Today: News, Analyst Forecasts, Dividend Outlook, and What’s Driving Shares on Dec. 23, 2025

Philip Morris International stock rose 1.4% to $161.94 as of 2:37 p.m. ET Tuesday, following a 1.82% gain Monday. Shares remain below the 52-week high of $186.69 set in June. The company secured a new $2 billion revolving credit facility and extended a €1.5 billion facility, both detailed in a Dec. 23 Form 8-K filing. No borrowings were outstanding under the replaced facility at the time of the change.
23 décembre 2025
·
Eli Lilly Stock (LLY) After Hours Today (Dec. 23, 2025): What Happened After the Bell—and What to Watch Before the Market Opens Dec. 24

Eli Lilly Stock (LLY) After Hours Today (Dec. 23, 2025): What Happened After the Bell—and What to Watch Before the Market Opens Dec. 24

Eli Lilly shares closed down 0.45% at $1,071.64 on Tuesday after the FDA approved Novo Nordisk’s Wegovy pill, the first oral GLP‑1 drug for chronic weight management in the U.S. Novo shares rose on the news, while Lilly stock traded flat in after-hours. Investors focused on the competitive impact of the new oral treatment on Lilly’s obesity franchise. Trading volume reached about 2 million shares.
23 décembre 2025
··
1 … 52 53 54 55 56 … 170
Go toTop